Avista Healthcare Public Acquisition Corp.
Status: Closed Deal
U=S+W
W=S/2@11.5
| IPO Proceeds, $M | $310.00M |
|---|---|
| IPO Date | Oct 11, 2016 |
| CEO | David Burgstahler |
| Left Lead | Credit Suisse |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+[4] |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Organogenesis |
| Deal Announced | Aug 17, 2018 |
| Deal Size, $M | $673.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 10, 2018 |
| Amendment Vote | TBD |
| Closing Date | Dec 11, 2018 |
Formerly AHPA
ORGO
ORGOW
| Price | $2.95 |
|---|---|
| Last closing price | $2.97 |
| H/L, today | $2.90 / $2.99 |
| H/L, 52-week | $1.80 / $4.50 |
| Volume, today | 609,283 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.